Skip to search formSkip to main contentSkip to account menu

40 ML bezlotoxumab 25 MG/ML Injection [Zinplava]

Known as: bezlotoxumab 25 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [ZINPLAVA], Zinplava 1000 MG in 40 ML Injection, 40 ML Zinplava 25 MG/ML Injection 
National Institutes of Health

Related topics

Related topics

11 relations

Broader (1)

40 ML bezlotoxumab 25 MG/ML Injection
InjectionPentetic AcidPolysorbate 80Sodium Chloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Zinplava® — reduziert das Rekurrenzrisiko einer Clostridium-difficile-Infektion
2018
2018
Bezlotoxumab (▼ Zinplava®) en infección por Clostridium difficile
El bezlotoxumab es un anticuerpo monoclonal humano que se une con una elevada afinidad a la toxina B del Clostridium difficile y… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)